T lymphocytes are known to exert both positive and negative regulatory controls on effector cells in the immune response. The positive helper effects on antibody production were recognized first (1, 2) . Later, suppressor functions were demonstrated in humoral immune responses (3) (4) (5) and more recently in delayed hypersensitivity (6) and the mixed lymphocyte reaction (MLR) (7) .' It is now clear from the work of Cantor and Boyse (8) that there are two types of regulatory T lymphocytes, helper and suppressor cells, which belong to separate populations distinguishable by their Ly surface antigens.
Like helper T cells, suppressor T cells appear to be genetically controlled by the major histocompatibility complex (MHC). These regulatory genes map in the I region of the mouse MHC (H-2), which is serologically divisable into A, B, J, E, and C regions. Kapp et al. (9) showed that the immune response to the synthetic peptide L-glutamic acid6°-L-alanine3°-L-tyrosine TM in mice was regulated by an antigen-specific immune suppression gene. Tada et al. (10) have shown that immune T cells can release a supernatant factor which specifically suppresses the immune response of other mouse strains that share the same I-J region genotype. Rich and Rich (11) have also shown that the suppressor T cell in the MLR can release a factor that suppresses the response of responding cells sharing the same/-C region genotype. Murphy et al. (12) and Tada et al. (13) have shown that suppressor T cells express a unique I region determinant,/-J, on their surface.
Suppressor T cells are of interest in humans for two reasons. They may allow some insight into the controls on immune function exerted by the human MHC, the HLA system, and they may play roles in disease processes and organ transplantation. It has, for instance been suggested that they normally prevent the development of autoimmune disease processes (14) . There has been one report of suppressor cells in a human disease. Waldman et al. (15) showed that T methods. The first was based on the resetting techniques described by Wilson et al. (17) and modified by W. F. Bodmer, Oxford University, Great Britain (personal communication). Lymphocytes were suspended in RPMI -10% heat inactivated, sheep erythrocyte absorbed, fetal calf serum (FCS) at 5 x l0 s cells/ml. An equal vol of 0.7% papain-treated sheep erythrocytes was added and the mixture allowed to stand for 15 min. The cells were then pelleted by centrifuging for 5 min at 800 rpm. The rosettes were then allowed to become more stable by incubating on ice. After 1 h the cells were layered onto 10% Ficoll-Isopaque and centrifuged at 1,200 rpm for 30 min. The B cells at the interface were collected and washed once in RPMI-10% normal human serum. The T-cell rosettes were incubated in 100% pooled heat-inactivated human A serum for 1 h at 37°C and then separated on 9% Ficoll-Isopaque. The efficiency of this method was checked by reresetting samples of the B-and T-cell preparations and counting the number of rosettes compared to nonrosetted lymphocytes.
The second method depended on B lymphocytes binding to solid phase anti-immunoglobulin. 2 ml of Cohn Fraction II (Mann Research Laboratories, Inc., New York) immunoglobulin at 2 mg/ml and water-soluble carbodiimide at 1 mg/ml in PBS were pipetted into a plastic tissue culture flask (Falcon Plastics, Division of BioQuest, Oxnard, Calif.). This flask was incubated on its side at room temperature for 1 h and then washed three times with PBS-5% FCS. Then 2 ml of a 1:20 dilution of rabbit anti-human immunoglobulin was added, incubated for 30 min at room temperature, and the flask washed out with PBS-5% FCS. 1.5 x 107 peripheral lymphocytes in RPMI-10% FCS were then added and allowed to stand for 30 min at room temperature. The nonadherent T cells were then decanted off and the B cells removed after 2 h incubation at 37°C with RPMI-50% human A serum containing 1.26 mM EDTA. T cells were counted for the two fractions by rosetting. Cell recovery was normally 75-90%.
Antibody-Mediated Lympholysis. The method described by Kovithavongs et al. (16) was used. Lymphocytes were prepared as described above and erythrocytes lysed by a 5-s hypotonic shock. 5 × 10 ~ target cells in 0.1 ml RPMI/10% FCS were labeled by incubating with I00 ~Ci chromium 51 (New England Nuclear) for I h at 37°C with shaking. To 2 × 10 s effector cells (J.H.) in 1 ml RPMI/ 10% FCS was added 0.025 /~l of labeled targets in duplicate. 0.1 rnl of normal human serum (antibody) was then added and the mixture incubated for 4 h at 37°C. The cells were centrifuged to a pellet and the chromium 51 released into the supernate was counted in a 7-counter. The fraction of chromium 51 released into the supernate was calculated as a percentage of the total radioactivity in each tube and the background release by target cells incubated alone was then subtracted. (Fig. 1) . However, as reported by Sasazuki et al. (16) she gave some unexpected results when tested as a responder against 39 homozygous typing cells (HTC) in the 1975 Histocompatibility Testing Workshop. She failed to respond (relative response less than 20%) to three DW2 HTC, and also to six other cells; she responded normally to 30 other HTCs. The nonstimulating cells did not fall into any single DW cluster but four of them shared HLA antigens of the 5 complex. It has also been found that her cells do not respond to some HLA-D heterozygous cells ( Table II) .
Results

Mixed
Evidence that the Low Response of J.H. to W.H.' is due to a Suppressor Cell. Because J.H. failed to respond to some cells that shared the BW35 specificity with her husband, it seemed possible that this might be due to specific suppression after multiple pregnancies. J.H. has 10 children, the youngest of whom was aged 9 yr at the time of these experiments. Because her husband is also HLA-B and D homozygous, she has therefore had repeated exposure to one HLA-B-D haplotype. She was originally investigated by Dr. Rose Payne because she made a good anti-HLA-BW35 antibody, during her childbearing years. At (Fig. 1 , Table HI ). This experiment also shows that the effect must be cellular because it is radiosensitive. Shown in Fig. 2 
Time-Course of the Suppressive Effects of J.H. Cells.
The previously described experiments were all harvested after 7-days culture which is normally the peak in the human MLR in this laboratory. If the three cell mixtures had accelerated kinetics it is possible that the apparent suppression at day 7 might, in fact, be the descending curve of an earlier peak. A time-course experiment was therefore carried out to exclude this possibility. Replicate cultures were set up on day 0 and harvested at days 3, 5, 7, and 9. These results (Figs. 3 and 4) show that the three cell mixtures also peaked at day 7 and that suppression was maximal at this time.
Evidence that the Suppressor Cell is a T Cell. Two methods of T-and B-cell separation were used in these experiments, one dependent on the ability of T cells to form rosettes with sheep erythrocytes and the other dependent on the failure of T cells to bind to anti-immunoglobulin. Both methods give T-cell 
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preparations that were 81-93% pure as judged by (re)rosetting; the B-cell preparations contained 11-24% rosetting cells. These figures compare¢~ with a percentage of 55-70% rosetting cells in unseparated blood lymphocytes. Table HI and Figs. 1 and 2 show the results of these experiments. T-and B-cell preparations were tested for their ability to suppress the response of T.I. to W.H. '. As 50,000 cells of each preparation were used it may be relevant that the relative numbers of T cells in the T-cell preparation were slightly increased, and of B cells in the B-cell preparation greatly increased. The experiment was thus biased towards finding a B-cell suppressor. The results showed that suppression was consistently enhanced by removing B cells and greatly reduced or abolished in the B-cell-rich preparations. The T-cell suppression was also reversible by high dose (6,000 rad) irradiation.
To eliminate the possibility of a nonspecific T-cell effect, the experiment was repeated by using separated T and B lymphocytes isolated from both J.H. and T.I. These cells were tested on K.M. Only T cells from J.H. suppressed the response to W.H.' (Fig. 2) Table IV . The proliferative response to four of these cells, including W.H., was suppressed. The response to the other five was greater than the control value T.I./X' as expected. J.H. lymphocytes therefore show antigen specificity in their suppressive effect. These findings are consistent with the finding that J.H. did not respond to certain stimulating cells (Table II) . Thus J.H. did not respond to W.H., J.L., or D.B. and when added to T.I. cells the net response of T.I. to each of these cells was reduced. J.H. did respond to S.P. however and the response of T.I. to this cell was suppressed. The J.H. suppressor cell therefore shows specificity when tested with a limited selection of cells and, with the exception of cell S.P., this specificity seems comparable to the pattern of low responsiveness seen when J.H. alone was tested as a responder with a panel of stimulating cells. Analysis of the HLA types of these stimulating cells (Tables II and IV) did not reveal an identifiable private specificity as the antigen recognized by the suppressor cell. It is most likely that this cell in fact recognizes one or more public specificities shared by MLR stimulating (I region) antigens of these cells. When J.H. peripheral blood cells (normally 10-20% B cells) were enriched for T cells the suppressive effect was enhanced. When J.H. cells were enriched for B cells the suppressive effect was always reduced and was reversed in two out of four experiments. These results strongly suggest that the effect is due to a T cell. The low degree of suppression seen with two of the B-cell preparations was probably due to contamination by T cells, which was as high as 20%. Suppression by a T-cell-dependent antibody producing B cell is very unlikely because of the above results. Also, the number of B cells present in 50,000 purified T cells was only around 2,500. In an active secondary response, only 1-2 of 2,500 B cells might be expected to secrete antibody specific of the antigen (W.H.) so that, in the unlikely event that culture conditions were appropriate, given a Poisson distribution of these B cells the effect would be extremely variable from well to well. Standard errors of the triplicates were usually within 10% of the mean (Figs. 1-4) . The possibility that J.H. T lymphocytes include a cytotoxic cell that killed the target either directly or by means of very small amounts of antibody carried over by the J.H. cells, was considered. A cytotoxic assay was performed under conditions very similar to the MLR culture, except that the killer:target (J.H.:W.H.) ratio was increased from 1:1 to 20:1. No increase of chromium release over the low levels seen with a control cell was seen and this mechanism is therefore unlikely. It is concluded that the suppression was due to a suppressor T (Ts) cell.
Experiments with different stimulating cells showed that the suppressor T cell showed antigen specificity. In a survey of the effect of J.H. on suppression of the response of T.I. to a limited series of stimulating cells, three cells were found that shared specificity with W.H. Two of these also failed to stimulate J.H. directly indicating that the two basic observations of a low response of J.H. cells to W.H.' and suppression of a third party response to W.H.' may share a common mechanism, the same Ts cell. The specificity this cell recognized did not fall into any recognized type and may represent a public specificity shared by the cells that fail to stimulate J.H. Ts cells have been described in a number of immune responses (3, 5, 10) . They can, in the mouse, be clearly distinguished by their Ly antigens (4) . Ts cells have been described in the MLR by Rich and Rich (7) and these results are in many ways similar to theirs in the mouse. However there are apparent differences. The suppressor cell described by Rich and Rich was mitomycin resistant whereas the J.H. cell was radio sensitive. The dose of irradiation used was high and recent data (A. J. McMichael and T. Sasazuki, unpublished observation) show that a lower dose of 1,500 rad left suppressor activity intact. The Ts cell of Rich and Rich was not antigen specific but this may reflect the relatively small numbers of antigenic differences tested in inbred mice compared to those between outbred humans. The J.H. Ts cell showed specificity for antigen though it did not fit in with any recognized pattern of a private HLA specificity. It is possible that the specificity is for a public specificity shared by the BW35-DWl haplotype and certain other HLA antigens, but not 3, 2, 7, or DW2.
This demonstration of antigen-specific Ts cells in humans raises questions about their relationship with the HLA system. In similar situations in mice Ts cells produce a suppressor factor which is active in suppressing T cells that share Ia determinants with the suppressor cells (10, 11) . Because of the allogeneic stimulation that would occur, it was not possible to test whether J.H. Ts cells would suppress the response of cells that did not carry HLA B7-DW2 to W.H.'. Experiments are in progress to generate a suppressor factor to answer this question. If antigen-specific suppression is shown to be controlled by the HLA complex and can be shown to be restricted to a particular subregion, this will have important bearing on understanding the mechanisms that underly HLA and disease associations.
Summary
Lymphocytes from an HLA-B7 DW2 homozygous multiparous woman, J.H., failed to respond in the mixed lymphocyte reaction to lymphocytes from her DWl homozygous husband, W.H., and certain other homozygous typing cells. J.H. lymphocytes could suppress the response of HLA matched responders to
